Proteome Sciences plc provided revenue guidance for 2013. For the year, revenue expected to show a significant increase over 2012 resulting from the strong performance across core activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 GBX | +4.92% | +18.08% | -10.60% |
May. 16 | Proteome Sciences promises AGM return to growth in 2024 | AN |
May. 16 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
1st Jan change | Capi. | |
---|---|---|
-10.60% | 15.21M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- PRM Stock
- News Proteome Sciences plc
- Proteome Sciences plc Provides Revenue Guidance for 2013